Lysophospholipids increase IL-8 and MCP-1 expressions in human umbilical cord vein endothelial cells through an IL-1-dependent mechanism
- 22 June 2006
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 99 (4) , 1216-1232
- https://doi.org/10.1002/jcb.20963
Abstract
Lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) are both low-molecular-weight lysophospholipid (LPL) ligands which are recognized by the Edg family of G protein-coupled receptors (GPCRs). In endothelial cells, these two ligands activate Edg receptors resulting in cell proliferation and cell migration. Interleukin-8 (IL-8) is a C-X-C chemokine and acts as a chemoattractant of neutrophils, whereas monocyte chemoattractant protein-1 (MCP-1) is a C-C chemokine and functions mainly as a chemoattractant of monocytes/macrophages. Both factors are secreted from endothelial cells and have been implicated in the processes leading to atherosclerosis. We examined the effects of LPLs on the expression of IL-8 and MCP-1, key regulators of leukocyte recruitment in human umbilical cord vein endothelial cells (HUVECs). Work illustrated in this article showed that LPA and S1P enhanced IL-8 and MCP-1 mRNA expressions, and protein secretions in dose- and time-dependent fashions. Maximal mRNA expression appeared at 16 hr post-ligand treatment. Using prior treatments with chemical inhibitors, LPLs enhanced IL-8 and MCP-1 expressions through a Gi-, Rho-, and NFκB-dependent mechanism. In a chemotaxis assay system, LPL treatments of endothelial cells enhanced monocyte recruitment through upregulating IL-8 and MCP-1 protein secretions. Pre-incubation with AF12198, an IL-1 receptor antagonist or IL-1 functional blocking antibody both suppressed the enhanced effects elicited by LPLs of IL-8 and MCP-1 mRNA expressions in HUVECs. These results suggest that LPLs released by activated platelets might enhance the IL-8- and MCP-1-dependent chemoattraction of monocytes toward the endothelium through an IL-1-dependent mechanism, which may play an important role in facilitating wound-healing and inflammation processes. J. Cell. Biochem. 99: 1216–1232, 2006.Keywords
This publication has 68 references indexed in Scilit:
- Sphingosine-1-Phosphate Prevents Tumor Necrosis Factor-α–Mediated Monocyte Adhesion to Aortic Endothelium in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1β and TNF-α induced production of inflammatory mediatorsCellular Signalling, 2005
- Sphingosine kinase-1 mediates TNF-α-induced MCP-1 gene expression in endothelial cells: upregulation by oscillatory flowAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Protein Kinase Cδ Mediates Lysophosphatidic Acid-induced NF-κB Activation and Interleukin-8 Secretion in Human Bronchial Epithelial CellsJournal of Biological Chemistry, 2004
- Topical application of the phospholipid growth factor lysophosphatidic acid promotes wound healing in vivoAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2001
- A growing family of receptor genes for lysophosphatidic acid (LPA) and other lysophospholipids (LPs)Cell Biochemistry and Biophysics, 1999
- Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphateJournal of Cellular Biochemistry, 1998
- Human Chemokines: An UpdateAnnual Review of Immunology, 1997
- AF12198, a Novel Low Molecular Weight Antagonist, Selectively Binds the Human Type I Interleukin (IL)-1 Receptor and Blocks in Vivo Responses to IL-1Published by Elsevier ,1996
- Monocyte Chemotactic Protein-3 (MCP3) Interacts with Multiple Leukocyte ReceptorsPublished by Elsevier ,1995